Literature DB >> 10050776

Hairpin-shaped DNA duplexes with disulfide bonds in sugar-phosphate backbone as potential DNA reagents for crosslinking with proteins.

N Dolinnaya1, V Metelev, T Oretskaya, D Tabatadze, Z Shabarova.   

Abstract

Convenient approaches were described to incorporate -OP(=O)O(-)-SS-O(-)(O=)PO- bridges in hairpin-shaped DNA duplexes instead of regular phosphodiester linkages: (i) H2O2- or 2,2'-dipyridyldisulfide-mediated coupling of 3'- and 5'-thiophosphorylated oligonucleotides on complementary template and (ii) more selective template-guided autoligation of a preactivated oligonucleotide derivative with an oligomer carrying a terminal thiophosphoryl group. Dithiothreitol was found to cleave completely modified internucleotide linkage releasing starting oligonucleotides. The presence of complementary template as an intrinsic element of the molecule protects the hairpin DNA analog from spontaneous exchange of disulfide-linked oligomer fragments and makes it a good candidate for auto-crosslinking with cysteine-containing proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050776     DOI: 10.1016/s0014-5793(99)00059-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  New chemically reactive dsDNAs containing single internucleotide monophosphoryldithio links: reactivity of 5'-mercapto-oligodeoxyribonucleotides.

Authors:  V G Metelev; O A Borisova; E M Volkov; T S Oretskaya; N G Dolinnaya
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

Review 2.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

3.  Switchable conformational changes of DNA nanogel shells containing disulfide-DNA hybrids for controlled drug release and efficient anticancer action.

Authors:  Wioletta Liwinska; Iwona Stanislawska; Marek Lyp; Zbigniew Stojek; Ewelina Zabost
Journal:  RSC Adv       Date:  2019-05-03       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.